![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » STERLING BIOTECH Q1 NET RISES 23.16% TO RS 302.354 MILLION
STERLING BIOTECH Q1 NET RISES 23.16% TO RS 302.354 MILLION
April 28, 2006
Sterling Biotech Ltd has posted 23.16% increase in net profit to Rs 302.354 million for the quarter ended March 31, 2006 as compared to Rs 245.484 million for the quarter ended March 31, 2005. Total Income has increased by 21.72% to Rs 1346.958 million for Q1 FY 2006 from Rs 1106.546 million in Q1 FY 2005 to Rs 1346.958 million for Q1 FY 2006.
Myiris.com (http://www.myiris.com/newsCentre/newsPopup.php?fileR=20060428160646043&dir=2006/04/28&secID=livenews)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct